Status:
RECRUITING
Lung Transplant READY CF 2: CARING CF Ancillary RCT
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Cystic Fibrosis Foundation
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the United States, more people with CF and low lung function die each year than undergo lung transplant. Mo...
Detailed Description
Lung transplant is an option for treating end-stage lung disease in cystic fibrosis (CF). In the US, more CF patients with forced expiratory volume in 1 second (FEV1) less than 30% of predicted die ea...
Eligibility Criteria
Inclusion
- Identified as a caregiver or loved one of an individual with CF enrolled in the Lung Transplant READY CF 2 parent RCT, or
- An individual with CF enrolled in the Lung Transplant READY CF 2 parent RCT
Exclusion
- People who are unable to provide informed consent
- Unable to read or understand English or Spanish to complete surveys or access the website (currently only available in English and Spanish)
Key Trial Info
Start Date :
September 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2027
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT06032273
Start Date
September 6 2023
End Date
July 31 2027
Last Update
December 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Washington Medical Center - Montlake
Seattle, Washington, United States, 98195